@illumina are finally getting some NGS competition

By | December 8th, 2021|Categories: Next-generation sequencing|Tags: , , , |3 Comments

The news (thanks @danravicher) from the recent Illumina vs BGI_MGI that the invalidity of the ‘444 patent means BGI_MGI can enter the US market in 2022 was very interesting. Does it mean Illumina are worrying about new competition – I am not so sure. The […]